Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 4, 2007, Pages 382.e1-382.e8

  Norwitz, Errol R ^a   Snegovskikh, Victoria ^a   Schatz, Frederick ^a   Foyouzi, Nastaran ^a   Rahman, Mizanur ^a   Buchwalder, Lynn ^a   Lee, Hee Joong ^a   Funai, Edmund F ^a   Buhimschi, Catalin S ^a   Buhimschi, Irina A ^a   Lockwood, Charles J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

decidua; labor; PAI 1; plasminogen activator system; thrombin; tPA; uPA

Indexed keywords

CYTOKINE; DRUG VEHICLE; ESTRADIOL; GESTAGEN; HIRUDIN; INTERLEUKIN 1BETA; MEDROXYPROGESTERONE ACETATE; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROID HORMONE; THROMBIN; THROMBIN INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ADULT; ARTICLE; BIRTH; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABOR INDUCTION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SOLUTIO PLACENTAE; UTERUS CONTRACTION; WESTERN BLOTTING;

EID: 33947623608     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.02.035     Document Type: Article

References (22)

1. Vassalli J.D., Sappino A.P., and Belin D. The plasminogen activator/plasmin system. J Clin Invest 88 (1991) 1067-1072
2. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 823 (1985) 35-65
3. Baricos W.H., Cortez S.L., el-Dahr S.S., and Schnaper H.W. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47 (1995) 1039-1047
4. Monea S., Lehti K., Keski-Oja J., and Mignatti P. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol 192 (2002) 160-170
5. Casey M.L., and MacDonald P.C. Biomolecular processes in the initiation of parturition: decidual activation. Clin Obstet Gynecol 31 (1988) 533-552
6. Mackenzie A.P., Schatz F., Krikun G., Funai F.F., Kadner S., and Lockwood C.J. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 191 (2004) 1996-2001
7. Rosen T., Schatz F., Kuczynski E., Lam H., Koo A.B., and Lockwood C.J. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 11 (2002) 11-17
8. Lockwood C.J., Paidas M., Krikun G., et al. Inflammatory cytokine and thrombin regulation of interleukin-8 and intercellular adhesion molecule-1 expression in first trimester human decidua. J Clin Endocrinol Metab 90 (2005) 4710-4715
9. Elovitz M.A., Baron J., and Phillipe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 185 (2001) 1059-1063
10. Norwitz E.R., Starkey P.M., and Lopez Bernal A. Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. Obstet Gynecol 80 (1992) 440-445
11. Norwitz E.R., and Wilson T. Secretory component: a potential regulator of endometrium/decidual prostaglandin production in early human pregnancy. Am J Obstet Gynecol 183 (2000) 108-117
12. Koopman L.A., Kopcow H.D., Rybalov B., et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198 (2003) 1201-1212
13. Norwitz E.R., Robinson J.N., and Challis J.R.G. The control of labor. N Engl J Med 341 (1999) 660-666
14. Challis J.R.G., Matthews S.G., Gibb W., and Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocrine Rev 21 (2000) 514-550
15. Condon J.C., Jeyasuria P., Faust J.M., Wilson J.W., and Mendelson C.R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 100 (2003) 9518-9523
16. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11 (2004) 193-202
17. Neilson J.P. Mifepristone for induction of labour. Cochrane Database Syst Rev (2000) CD002865
18. Meis P.J., Klebanoff M., Thom E., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
19. Da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
20. Williams M.A., Mittendorf R., Lieberman E., and Monson R.R. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 78 (1991) 14-18
21. Salafia C.M., Lopez-Zeno J.A., Sherer D.M., Whittington S.S., Minior V.K., and Vintzileos A.M. Histologic evidence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 173 (1995) 1065-1070
22. Lockwood C.J., Krikun G., and Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann N Y Acad Sci 943 (2001) 77-88